Companies: 10,795·Total market cap: $144.5T
Evolent Health, Inc.

Evolent Health, Inc.

EVHNYSEHealthcare● Active
$4.66
+$0.44(+10.43%)
Market Cap$524161772
P/E Ratio
52W High$12.065
52W Low$2.095
Overview

Evolent Health, Inc. (EVH) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001628908 · EVH · NYSE · as of Jun 8, 2026

Filing snapshot

835
Total Filings
8-K
Latest Form
2026-06-04
Most Recent
2015
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001628908 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-02-25
Fiscal Year End
Feb 25, 2026
Accession No.
0001628908-26-000015
Primary Document
evh-20251231.htm
Source: data.sec.gov · CIK 0001628908 · Accession 0001628908-26-000015

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
8-KCurrent Report
8-K
2026-06-04Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-04
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
ARSARS
ARS
2026-04-24
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-24
View
DEF 14AProxy Statement
DEF 14A
2026-04-24
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-03-26
View
10-KAnnual Report
10-K
2026-02-25
View
8-KCurrent Report
8-K
2026-02-24
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-13
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-11
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-05
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-01-30
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-01-05
View
S-8Employee Stock Plan Registration
S-8
2026-01-02
View
Showing 1–15 of 454 filingsForm 4 / 144 hidden· 835 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001628908  |  Exchange: NYSE · Healthcare

Evolent Health, Inc. (NYSE: EVH) has submitted 835 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001628908, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Evolent Health, Inc.'s most comprehensive regulatory disclosure. The most recent Evolent Health, Inc. 10-K was filed on 2026-02-25 for fiscal year ending 2026. Historical EVH 10-K annual reports are available from 2014 through 2026.

Investors researching Evolent Health, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

EVH SEC Filings · 8 questions

Evolent Health, Inc. (EVH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 835 filings and access original documents at no cost. Evolent Health, Inc.'s CIK is 0001628908.

EVH SEC filingsEvolent Health, Inc. SEC documentsfind EVH 10-K